Search - tctmd.com

Displaying 101 - 120 of 228

Sort: Relevancy | Date

Presentation TCT 2015

TWENTE: A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease Five-Year Outcomes

Presenter: Bernard J. Gersh, Thomas F. Luscher, Clemens von Birgelen

October 14, 2015

News Conference News TCT 2015

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

October 14, 2015

Presentation TCT 2015

SORT-OUT VI: A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Bioabsorbable-Polymer Biolimus-Eluting Stent in Patients With Coronary Artery Disease Three-Year Outcomes

Presenter: David P. Faxon, David O. Williams, Bent Raungaard

October 13, 2015

News Conference News TCT 2015

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

October 13, 2015

News Conference News TCT 2015

Debaters Question Need for Further Stent Innovation

Todd Neale

October 13, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

Presentation TCT 2015

Why Contemporary Durable Polymers Are Not Good Enough. Do Any of the Current Bioabsorbable Polymers Make the Grade?

Presenter: Pieter C. Smits, Philip M. Urban, Renu Virmani

October 12, 2015

Presentation TCT 2015

Stentys Self-Expanding Stent With a Durable Polymer Eluting Sirolimus: Extended 2-Year Clinical and OCT Results From APPOSITION IV

Presenter: Fernando Alfonso, Juan F. Granada, Robert-Jan van Geuns

October 12, 2015

Presentation TCT 2015

A New Durable-PolymerBased Cobalt Chromium Stent: Rationale for and Design Characteristics of the BioNIR Stent and Clinical Development Program

Presenter: Fernando Alfonso, Juan F. Granada, Pieter C. Smits

October 12, 2015

Presentation TCT 2015

Microengineered Grooved Stent Surfaces and Beyond: Technology Description and Preliminary Data

Presenter: Fernando Alfonso, Juan F. Granada

October 12, 2015

Presentation TCT 2015

Debate: Can Todays Metallic Stent Platforms, Delivery Systems, and Durable Polymers Be Meaningfully Improved? No, the Bench, Experimental, and Clinical Results Are So Good, We Probably Have Reached a Therapeutic Plateau!

Presenter: Fernando Alfonso, Juan F. Granada, Lisette Okkels Jensen

October 12, 2015

Presentation TCT 2015

Debate: Can Todays Metallic Stent Platforms, Delivery Systems, and Durable Polymers Be Meaningfully Improved? Yes, Made Thinner and More Flexible, With Optimally Designed Platforms and Enhanced Polymers There Is Still Room for Improvement!

Presenter: Fernando Alfonso, Juan F. Granada, Elazer R. Edelman

October 12, 2015

Presentation TCT 2015

CENTURY II: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease Two-Year Outcomes

Presenter: Spencer B. King III, Jagat Narula, Shigeru Saito

October 12, 2015

Presentation TCT 2015

Durable-Polymer DES 5-Year Outcomes: RESOLUTE Update

Presenter: Stephen G. Ellis, John A. Ormiston, Sigmund Silber

October 11, 2015

Presentation TCT 2015

Durable-Polymer DES 5-Year Outcomes: XIENCE/PROMUS and PROMUS Element Update

Presenter: Stephen G. Ellis, John A. Ormiston, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? No, This Theoretical Goal Does Not Hold Up Under Scrutiny!

Presenter: Stephen G. Ellis, John A. Ormiston, Tullio Palmerini

October 11, 2015

Presentation TCT 2015

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? Yes, Eliminating the Polymer to Leave Behind a Bare-Metal Stent Surface Is a Desirable and Clinically Meaningful Goal!

Presenter: Stephen G. Ellis, John A. Ormiston, Robert A. Byrne

October 11, 2015

Presentation TCT 2015

Clinical Outcomes of Current-Generation Durable-Polymer Drug-Eluting Stents: More Alike or Different?

Presenter: Stephen G. Ellis, John A. Ormiston, Sripal Bangalore

October 11, 2015

Presentation TCT 2015

Design of Current-Generation Durable-Polymer Drug-Eluting Stents: More Alike or Different?

Presenter: Stephen G. Ellis, John A. Ormiston

October 11, 2015

News Daily News

Meta-analysis Confirms Late Safety of Second-Generation DES

L.A. McKeown

June 10, 2015

Advertisement

TWENTE: A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease Five-Year Outcomes

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

SORT-OUT VI: A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Bioabsorbable-Polymer Biolimus-Eluting Stent in Patients With Coronary Artery Disease Three-Year Outcomes

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

Debaters Question Need for Further Stent Innovation

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

Why Contemporary Durable Polymers Are Not Good Enough. Do Any of the Current Bioabsorbable Polymers Make the Grade?

Stentys Self-Expanding Stent With a Durable Polymer Eluting Sirolimus: Extended 2-Year Clinical and OCT Results From APPOSITION IV

A New Durable-PolymerBased Cobalt Chromium Stent: Rationale for and Design Characteristics of the BioNIR Stent and Clinical Development Program

Microengineered Grooved Stent Surfaces and Beyond: Technology Description and Preliminary Data

Debate: Can Todays Metallic Stent Platforms, Delivery Systems, and Durable Polymers Be Meaningfully Improved? No, the Bench, Experimental, and Clinical Results Are So Good, We Probably Have Reached a Therapeutic Plateau!

Debate: Can Todays Metallic Stent Platforms, Delivery Systems, and Durable Polymers Be Meaningfully Improved? Yes, Made Thinner and More Flexible, With Optimally Designed Platforms and Enhanced Polymers There Is Still Room for Improvement!

CENTURY II: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease Two-Year Outcomes

Durable-Polymer DES 5-Year Outcomes: RESOLUTE Update

Durable-Polymer DES 5-Year Outcomes: XIENCE/PROMUS and PROMUS Element Update

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? No, This Theoretical Goal Does Not Hold Up Under Scrutiny!

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? Yes, Eliminating the Polymer to Leave Behind a Bare-Metal Stent Surface Is a Desirable and Clinically Meaningful Goal!

Clinical Outcomes of Current-Generation Durable-Polymer Drug-Eluting Stents: More Alike or Different?

Design of Current-Generation Durable-Polymer Drug-Eluting Stents: More Alike or Different?

Meta-analysis Confirms Late Safety of Second-Generation DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content